Litcius/Paper detail

Metabolic disposition of the EGFR covalent inhibitor furmonertinib in humans

Jian Meng, Hua Zhang, Jingjing Bao, Zhendong Chen, Xiaoyun Liu, Yifan Zhang, Yong Jiang, Li-yan Miao, Dafang Zhong

2021Acta Pharmacologica Sinica22 citationsDOIOpen Access PDF

Topics & Concepts

MetabolitePharmacokineticsPharmacologyChemistryUrineDrugFecesOral administrationMetabolismMedicineBiologyBiochemistryPaleontologyLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research
Metabolic disposition of the EGFR covalent inhibitor furmonertinib in humans | Litcius